From: Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study
 | Median TCC duration |  | |||
---|---|---|---|---|---|
Variable | Total (N = 27) | <  4 months (n = 12) | >  4 months (n = 15) | OR (95% CI) | P-value* |
Charcot foot | |||||
 Left, n (%) | 14 (51.9) | 4 (33.3) | 10 (66.7) | 4.00 (0.80 to 20.02) | 0.085 |
 Right, n (%) | 13 (48.1) | 8 (66.7) | 5 (33.3) | 0.25 (0.05 to 1.25) | 0.085 |
Stage of Charcot | |||||
 Stage 0, n (%) | 0 (0) | 0 (0) | 0 (0) | N/A | N/A |
 Stage 1, n (%) | 27 (100.0) | 12 (100.0) | 15 (100.0) | N/A | N/A |
Median Charcot duration (IQR), monthsa,b | 2.0 (1.0 to 6.0) | 2.5 (1.0 to 6.0) | 1.8 (0.9 to 6.8) | N/A | 0.709†|
Charcot trigger | |||||
 Ulceration, n (%) | 9 (33.3) | 5 (41.7) | 4 (26.7) | 0.51 (0.10 to 2.57) | 0.448 |
 Injury/trauma, n (%) | 14 (51.9) | 5 (41.7) | 9 (60.0) | 2.10 (0.45 to 9.84) | 0.343 |
 Amputation, n (%) | 2 (7.4) | 2 (16.7) | 0 (0) | 1.20 (0.93 to 1.55) | 0.188 |
 Lymphoedema, n (%) | 1 (3.7) | 0 (0) | 1 (6.7) | 0.93 (0.82 to 1.07) | >  0.99 |
 Unknown, n (%) | 1 (3.7) | 0 (0) | 1 (6.7) | 0.93 (0.82 to 1.07) | >  0.99 |
Charcot misdiagnosis, n (%) | 17 (63.0) | 7 (58.3) | 10 (66.7) | 1.43 (0.30 to 6.88) | 0.706 |
Charcot pattern | |||||
 Tarsometatarsal joints, n (%) | 12 (44.4) | 5 (41.7) | 7 (46.7) | 1.23 (0.27 to 5.67) | 0.795 |
 NC, TN, CC joints, n (%) | 11 (40.7) | 6 (50.0) | 5 (33.3) | 0.50 (0.11 to 2.38) | 0.452 |
 Ankle and subtalar joints, n (%) | 1 (3.7) | 0 (0) | 1 (6.7) | 0.93 (0.82 to 1.07) | >  0.99 |
 Combination, n (%)c | 3 (11.1) | 1 (8.3) | 2 (13.3) | 1.69 (0.14 to 21.3) | >  0.99 |
Imaging received | |||||
 X-ray, n (%) | 27 (100.0) | 12 (100.0) | 15 (100.0) | N/A | N/A |
 Bone scan, n (%) | 4 (14.8) | 0 (0) | 4 (26.7) | 0.73 (0.54 to 1.00) | 0.106 |
 MRI, n (%) | 4 (14.8) | 2 (16.7) | 2 (13.3) | 0.77 (0.09 to 6.45) | >  0.99 |